Biosimilars Forum

Biocon Biologics’ strategic collaboration with Civica Inc. to supply Insulin Aspart drug substance will help address the critical need for accessible insulins in the U.S. As we continue to innovate and form impactful partnerships, we remain steadfast in our commitment. to transforming the diabetes landscape, improving patient outcomes, and reducing healthcare costs in the U.S. and beyond. Read More: https://bit.ly/PR20250306

Biosimilars are driving competition and lowering costs for patients who need life-saving medications. But we need policies that ensure all American patients can access these lower-cost alternatives. Learn more about the benefits of #biosimilars: https://lnkd.in/eC2Y89FA?

The #biosimilars industry continues to prioritize cost-savings to both patients and the healthcare system. The Biosimilars Forum is proud to support Americans by fighting for access to lower-cost medicines. Register for DIA's Evolution of Biosimilars Development to learn more about the advancement of biosimilars in the U.S. healthcare system: https://lnkd.in/eQaVhha6

#Biosimilars represent one of the greatest opportunities to lower healthcare costs, but PBMs are standing in the way. Instead of providing access to FDA-approved, lower-cost biosimilars, PBMs block competition and push high-rebate drugs to protect their bottom line. Congress and the Administration must step in. We need #PBMReform now to ensure patients—not middlemen—benefit from prescription drug savings.?

In the last ten years, #biosimilars have been associated with savings of $56 billion compared to what spending would have been without biosimilars. The next five years could see an increase in savings up to $181 billion as newly approved biosimilars launch and existing biosimilars see continued uptake. Join the Biosimilars Forum and its members at DIA's Evolution of Biosimilars Development by registering here: https://lnkd.in/eQaVhha6

We are only one month away from joining hundreds of healthcare leaders, experts, and innovators at the Festival of Biologics USA 2025. Sign up for the conference here: https://lnkd.in/dc2a5WW #festivalofbiologics

Biosimilars provide a safe, effective, and lower-cost solution to skyrocketing drug costs at a time when savings to the Medicare program can enable coverage of new, innovative medicines and protect the program. The introduction of biosimilars leads to lower costs and offers increased access to patients — a clear win for this Administration and Congress.?

Biosimilars have the potential to save the U.S. nearly $181 billion over the next five years. These life-saving medicines eliminate waste in the U.S. healthcare system by lowering costs, driving competition, and expanding access. Learn more: https://lnkd.in/eWV6vi-a?

The Biosimilars Forum is looking forward to joining hundreds of healthcare leaders and experts at this year’s Festival of Biologics USA 2025. Join the Forum on the April 23 and 24 to support lower-cost medicines for Americans. Learn more here: https://lnkd.in/dc2a5WW #festivalofbiologics

The Biosimilars Forum is partnering with DIA to promote biosimilars at the Evolution of Biosimilars Development Workshop. Join the Forum and hundreds of attendees at the workshop by signing up here: https://lnkd.in/eQaVhha6